Building bridges…

XCQTE builds bridges between science en business. We support and accelerate commercialization of biotech innovations. Main activities are business development and medical affairs. Our approach is progressive, pragmatic, and always goal oriented. XCQTE aims to add value by helping biotechs to make new therapies available to patients fast.

Dynamics in the pharmaceutical industry have changed radically. The biotech revolution is full steam ahead and maturing fast. Ever since the genome has been unraveled, many new targets and pathways have been identified. New technologies are capable of screening billions of compounds fast and selecting the most favorable lead compounds. The number of innovations and biotech companies are growing fast. XCQTE has to its disposal an extensive biotech network, knowledge and experience.

Innovation drives pharma. New products gain value as their chances to successful market introduction increase. However, biotechs are faced with increasing competition. Smaller markets for selected patient groups are created by developing drugs with more specific mechanisms of action. Often, several new drugs are being launched in the same market simultaneously. Price and market share of innovative drugs have never been so much under pressure in history before. To date, speed and quality in product development are more important than ever before. XCQTE supports biotechs with commercialization of new products through bridging business and science.

Building bridges…

News & Info Links